Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly, NCATS team on 'Wikipedia' of drug development

This article was originally published in Scrip

Executive Summary

Like the nine lives of cats, drugs like Merck's Vioxx (rofecoxib) – declared dead in 2004 after being linked to serious adverse cardiovascular events – could potentially be revived if a collaboration between the US National Institutes of Health's (NIH) newly created National Center for Advancing Translational Sciences (NCATS) and Lilly is successful.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC016608

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel